Correction to: Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer
Journal of Translational Medicine volume 19, Article number: 435 (2021)
Correction to: J Transl Med (2019) 17:253 https://doi.org/10.1186/s12967-019-2008-y
The authors of the original article  have found out after publication that there were 2 figure errors in the article:
The ROC curves of the CCL20-IL-17A panel in Figure 4C and 4D were the same as that in the Figure 5B and 5C.
There is an image crack in the Figure 5A during a layer merging process.
These changes don’t affect any conclusions of the original paper.
The incorrect (Figs. 1 and 2) and correct figures (Figs. 3 and 4) are published in this correction article. The areas with the errors are indicated with a blue box. The original article has been updated.
Wang D, Yuan W, Wang Y, Wu Q, Yang L, Li F, Chen X, Zhang Z, Yu W, Maimela NR, Cao L, Wang D, Wang J, Sun Z, Liu J, Zhang Y. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer. J Transl Med. 2019;17:253. https://doi.org/10.1186/s12967-019-2008-y.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Wang, D., Yuan, W., Wang, Y. et al. Correction to: Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer. J Transl Med 19, 435 (2021). https://doi.org/10.1186/s12967-021-03107-7